Expression of MIR-21 and Mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer

PLoS ONE

Volumn 6, Issue 12, 2011, Pages

  Deftereos, Georgios ^a   Corrie, Simon R ^a   Feng, Qinghua ^a   Morihara, Janice ^a   Stern, Joshua ^a   Hawes, Stephen E ^a   Kiviat, Nancy B ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA TROPOMYOSIN; BIOLOGICAL MARKER; LYMPHOCYTE ANTIGEN; MICRORNA; MICRORNA 143; MICRORNA 21; PHOSPHATIDYLINOSITOL 3,4,5 TRISPHOSPHATE 3 PHOSPHATASE; PROGRAMMED CELL DEATH PROTEIN 4; TUMOR MARKER; UNCLASSIFIED DRUG; FORMALDEHYDE; MIRN143 MICRORNA, HUMAN; MIRN21 MICRORNA, HUMAN; PARAFFIN; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER INVASION; CONTROLLED STUDY; DISEASE MARKER; DOWN REGULATION; FEMALE; GENETIC ASSOCIATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; UPREGULATION; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; PATHOLOGY; TISSUE FIXATION; TUMOR CELL LINE; TUMOR GENE; UTERINE CERVIX; UTERINE CERVIX TUMOR;

CELL LINE, TUMOR; CERVIX UTERI; FEMALE; FORMALDEHYDE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, NEOPLASM; HUMANS; IMMUNOHISTOCHEMISTRY; MICRORNAS; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; PARAFFIN EMBEDDING; TISSUE FIXATION; UTERINE CERVICAL NEOPLASMS;

EID: 83355176577     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0028423     Document Type: Article

References (54)

1. Cowland JB, Hother C, Gronbaek K, (2007) MicroRNAs and cancer. APMIS 115: 1090-1106.
2. Lynam-Lennon N, Maher SG, Reynolds JV, (2009) The roles of microRNA in cancer and apoptosis. Biol Rev Camb Philos Soc 84: 55-71.
3. Reshmi G, Pillai MR, (2008) Beyond HPV: Oncomirs as new players in cervical cancer. Febs Letters 582: 4113-4116.
4. Paranjape T, Slack FJ, Weidhaas JB, (2009) MicroRNAs: tools for cancer diagnostics. Gut 58: 1546-1554.
5. Wang Y, Lee CGL, (2009) MicroRNA and cancer- focus on apoptosis. Journal of Cellular and Molecular Medicine 13: 12-23.
6. Lu J, Getz G, Miska EA, Alvarez-Saavedra E, Lamb J, et al. (2005) MicroRNA expression profiles classify human cancers. Nature 435: 834-838.
7. Kai-Hung W, Hwan-Wun L, Shih-Rung L, Da-Ching D, Tang-Yuan C, (2009) Field methylation silencing of the protocadherin 10 gene in cervical carcinogenesis as a potential specific diagnostic test from cervical scrapings. Cancer Science 9999.
8. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J, et al. (2010) Circulating microRNAs as Novel Minimally Invasive Biomarkers for Breast Cancer. Annals of Surgery 251: 499-505.
9. Holowaty P, Miller AB, Rohan T, To T, (1999) Natural history of dysplasia of the uterine cervix. Journal of the National Cancer Institute 91: 252-258.
10. Hawes SE, Kiviat NB, (1999) Screening for cervical cancer. In: Holmes K, Sparling P, Stamm W, Piot P, Wasserheit J, editors. Sexually transmitted diseases. 3rd ed New York McGraw-Hill pp. 1399-1408.
11. Lee JW, Choi CH, Choi JJ, Park YA, Kim SJ, et al. (2008) Altered MicroRNA expression in cervical carcinomas. Clinical Cancer Research 14: 2535-2542.
12. Wang X, Tang S, Le S-Y, Lu R, Rader JS, et al. (2008) Aberrant Expression of Oncogenic and Tumor-Suppressive MicroRNAs in Cervical Cancer Is Required for Cancer Cell Growth. PLoS One 3 Article No.: e2557.
13. Martinez I, Gardiner AS, Board KF, Monzon FA, Edwards RP, et al. (2008) Human papillomavirus type 16 reduces the expression of microRNA-218 in cervical carcinoma cells. Oncogene 27: 2575-2582.
14. Yao Q, Xu H, Zhang Q-Q, Zhou H, Qu L-H, (2009) MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells. Biochemical and Biophysical Research Communications 388: 539-542.
15. Yang ZZ, Chen S, Luau XJ, Li YX, Liu M, et al. (2009) MicroRNA-214 is Aberrantly Expressed in Cervical Cancers and Inhibits the Growth of HeLa Cells. IUBMB Life 61: 1075-1082.
16. Pereira PM, Marques JP, Soares AR, Carreto L, Santos MAS, (2010) MicroRNA expression variability in human cervical tissues. PLoS One 5: e11780.
17. Lui W-O, Pourmand N, Patterson BK, Fire A, (2007) Patterns of Known and Novel Small RNAs in Human Cervical Cancer. Cancer Res 67: 6031-6043.
18. Lai JC, Cheng YW, Chiou HL, Wu MF, Chen CY, et al. (2005) Gender difference in estrogen receptor alpha promoter hypermethylation and its prognostic value in non-small cell lung cancer. Int J Cancer 117: 974-980.
19. Grill J, Lamfers MLM, van Beusechem VW, Dirven CM, Pherai DS, et al. (2002) The organotypic multicellular spheroid is a relevant three-dimensional model to study adenovirus replication and penetration in human tumors in vitro. Molecular Therapy 6: 609-614.
20. Kaaijk P, Troost D, Dast PK, Leenstra S, Bosch DA, (1995) Long-term culture of organotypic multicellular glioma spheroids - a good culture model for studying. Neuropathology and Applied Neurobiology 21: 386-391.
21. Saitoh T, Mine T, Katoh M, (2002) Frequent up-regulation of WNT5A mRNA in primary gastric cancer. International Journal of Molecular Medicine 9: 515-519.
22. Lind GE, Thorstensen L, Lovig T, Meling GI, Hamelin R, et al. (2004) A CpG island hypermethylation profile of primary colorectal carcinomas and colon cancer cell lines. Molecular cancer 3: 28.
23. Hernandez A, Smith F, Wang QD, Wang XF, Evers BM, (2000) Assessment of differential gene expression patterns in human colon cancers. Annals of Surgery 232: 576-584.
24. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST, et al. (2007) MicroRNA-21 Regulates Expression of the PTEN Tumor Suppressor Gene in Human Hepatocellular Cancer. Gastroenterology 133: 647-658.
25. Slaby O, Svoboda M, Fabian P, Smerdova T, Knoflickova D, et al. (2007) Altered Expression of miR-21, miR-31, miR-143 and miR-145 Is Related to Clinicopathologic Features of Colorectal Cancer. Oncology 72: 397-402.
26. Zhu S, Si ML, Wu H, Mo YY, (2007) MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J Biol Chem 282: 14328-14336.
27. Si M-L, Zhu S, Wu H, Lu Z, Wu F, et al. (2006) miR-21-mediated tumor growth. 26: 2799-2803.
28. Sempere LF, Christensen M, Silahtaroglu A, Bak M, Heath CV, et al. (2007) Altered MicroRNA Expression Confined to Specific Epithelial Cell Subpopulations in Breast Cancer. Cancer Res 67: 11612-11620.
29. Iorio MV, Ferracin M, Liu C-G, Veronese A, Spizzo R, et al. (2005) MicroRNA Gene Expression Deregulation in Human Breast Cancer. Cancer Res 65: 7065-7070.
30. Esau C, Kang X, Peralta E, Hanson E, Marcusson EG, et al. (2004) MicroRNA-143 Regulates Adipocyte Differentiation. J Biol Chem 279: 52361-52365.
31. Asangani IA, Rasheed SAK, Nikolova DA, Leupold JH, Colburn NH, et al. (2007) MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. 27: 2128-2136.
32. Frankel LB, Christoffersen NR, Jacobsen A, Lindow M, Krogh A, et al. (2008) Programmed Cell Death 4 (PDCD4) Is an Important Functional Target of the MicroRNA miR-21 in Breast Cancer Cells. J Biol Chem 283: 1026-1033.
33. Zhang Z, Joh K, Yatsuki H, Zhao W, Soejima H, et al. (2007) Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells. Cancer Lett 247: 318-327.
34. El-Mansi MT, Williams AR, (2006) Evaluation of PTEN expression in cervical adenocarcinoma by tissue microarray. Int J Gynecol Cancer 16: 1254-1260.
35. Lee JS, Choi YD, Lee JH, Nam JH, Choi C, et al. (2006) Expression of PTEN in the progression of cervical neoplasia and its relation to tumor behavior and angiogenesis in invasive squamous cell carcinoma. J Surg Oncol 93: 233-240.
36. Wei NA, Liu SS, Leung TH, Tam KF, Liao XY, et al. (2009) Loss of Programmed cell death 4 (Pdcd4) associates with the progression of ovarian cancer. Mol Cancer 8: 70.
37. Sheedy FJ, Palsson-McDermott E, Hennessy EJ, Martin C, O'Leary JJ, et al. (2010) Negative regulation of TLR4 via targeting of the proinflammatory tumor suppressor PDCD4 by the microRNA miR-21. Nat Immunol 11: 141-147.
38. Singh P, Marikkannu R, Bitomsky N, Klempnauer KH, (2009) Disruption of the Pdcd4 tumor suppressor gene in chicken DT40 cells reveals its role in the DNA-damage response. Oncogene 28: 3758-3764.
39. Xia HHX, Talley NJ, (2001) Apoptosis in gastric epithelium induced by Helicobacter pylori infection: Implications in gastric carcinogenesis. American Journal of Gastroenterology 96: 16-26.
40. Birchall MA, Winterford CM, Allan DJ, Harmon BV, (1995) Apoptosis in normal epithelium, premalignant and malignant lesions of the oropharynx and oral cavity: a preliminary study. European journal of cancer Part B, Oral oncology 31B: 380-383.
41. Griffiths-Jones S, Saini HK, van Dongen S, Enright AJ, (2008) miRBase: tools for microRNA genomics. Nucl Acids Res 36: D154-158.
42. Griffiths-Jones S, Grocock RJ, van Dongen S, Bateman A, Enright AJ, (2006) miRBase: microRNA sequences, targets and gene nomenclature. Nucl Acids Res 34: D140-144.
43. Griffiths-Jones S, (2004) The microRNA Registry. Nucl Acids Res 32: D109-111.
44. Volinia S, Calin GA, Liu C-G, Ambs S, Cimmino A, et al. (2006) A microRNA expression signature of human solid tumors defines cancer gene targets. Proceedings of the National Academy of Sciences of the United States of America 103: 2257-2261.
45. Feng Q, Balasubramanian A, Hawes SE, Toure P, Sow PS, et al. (2005) Detection of Hypermethylated Genes in Women With and Without Cervical Neoplasia. Journal of the National Cancer Institute 97: 273-282.
46. Xi LF, Toure P, Critchlow CW, Hawes SE, Dembele A, et al. (2003) Prevalence of specific types of human papillomavirus and cervical squamous intraepithelial lesions in consecutive, previously unscreened, West-African women over 35 years of age. International Journal of Cancer 103: 803-809.
47. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L, (2006) HPV in the etiology of human cancer. Vaccine 24: 1-10.
48. American College of Obstetricians and Gynecologists (2008) ACOG Practice Bulletin No. 99: management of abnormal cervical cytology and histology. Obstet Gynecol 112: 1419-1444.
49. Brockenbrough JS, Souquet T, Morihara JK, Stern JE, Hawes SE, et al. (2011) Tumor 39-Deoxy-39-18F-Fluorothymidine (18F-FLT) Uptake by PET Correlates with Thymidine Kinase 1 Expression: Static and Kinetic Analysis of 18F-FLT PET Studies in Lung Tumors. Journal of Nuclear Medicine 52: 1181-1188.
50. Li T, Li D, Sha JJ, Sun P, Huang YR, (2009) MicroRNA-21 directly targets MARCKS and promotes apoptosis resistance and invasion in prostate cancer cells. Biochemical and Biophysical Research Communications 383: 280-285.
51. Guo JM, Miao Y, Xiao BX, Huan R, Jiang Z, et al. (2009) Differential expression of microRNA species in human gastric cancer versus non-tumorous tissues. Journal of Gastroenterology and Hepatology 24: 652-657.
52. Akao Y, Nakagawa Y, Kitade Y, Kinoshita T, Naoe T, (2007) Downregulation of microRNAs-143 and-145 in B-cell malignancies. Cancer Science 98: 1914-1920.
53. Clape C, Fritz V, Henriquet C, Apparailly F, Fernandez P, et al. (2009) miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice. PLoS ONE 4.
54. Wang C, Zhou Z, Wang L, Yang L, Zhou B, et al. (2009) Clinicopathological significance of microRNA-31,-143 and-145 expression in colorectal cancer. Disease Markers 26: 27-34.